Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to those with a biological valve, new research has found.

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter and full-year ended Dec. 31, 2024.

Despite guideline recommendations, the use of bioprosthetic heart valves has surpassed mechanical valves, but data from a large surgical database may lead to a reassessment of that practice.

CABG plus surgical aortic valve replacement for treatment of coronary disease and aortic stenosis was associated with better ...

Edwards Lifesciences shares rise as analyst upgrades stock, citing TAVR growth, margin expansion, and strategic business ...

Investors remain bullish on medical device makers, expecting them to benefit from still-high demand for surgical procedures, ...

HYDERABAD: Doctors at Citizens Hospital successfully treated a 72-year-old patient with severe aortic valve stenosis and ...

The Heart and Vascular center at Portneuf Medical Center recently marked its 400th transaortic valve replacement procedure.

The Heart Valve Devices Market is driven by advancements in aortic, mitral, tricuspid, and pulmonary valve technologies. It ...

JAMESTOWN — Two Sanford Health Fargo cardiology providers offer outreach services at Sanford Jamestown 2nd Ave. Clinic. Outreach services are offered on the second and fourth Wednesday of every month.

Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to ...